Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
Public ClinicalTrials.gov record NCT00294346. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Social Anxiety Disorder
Study identification
- NCT ID
- NCT00294346
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Avera Pharmaceuticals
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Interventions
- AV608 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2006
- Primary completion
- Nov 30, 2006
- Completion
- Nov 30, 2006
- Last update posted
- Feb 24, 2008
2006
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Birmingham Research Group, Inc. | Birmingham | Alabama | 35216 | — |
| Pivotal Research Centers | Mesa | Arizona | 85210 | — |
| Southwestern Research, Inc. | Beverly Hills | California | 90210 | — |
| Affiliated Research Institute | San Diego | California | 92108 | — |
| CNS Healthcare | Jacksonville | Florida | 32216 | — |
| Comprehensive Neuroscience, Inc. | St. Petersburg | Florida | 33702 | — |
| University of South Florida | Tampa | Florida | 33613 | — |
| DuPont Clinical Research, Inc. | Rockville | Maryland | 20852 | — |
| Capital Clinical Research Associates | Rockville | Maryland | — | — |
| Medical Research Network, LLC | New York | New York | 10024 | — |
| Hartford Research | Cincinnatti | Ohio | 45242 | — |
| IPS Research Company | Oklahoma City | Oklahoma | 73130 | — |
| Summit Research Network | Portland | Oregon | 97210 | — |
| Claghorn-Lesem Research Clinic, LLP | Bellaire | Texas | 77401 | — |
| Croft Group Research Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00294346, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 24, 2008 · Synced Jul 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00294346 live on ClinicalTrials.gov.